Table 2.
Management of chronic coronary syndromes during COVID-19 pandemic
| Continuation of medications in CCS patients is recommended during COVID-19 pandemic |
| Follow-up of CCS patients via tele-health is recommended |
| Revascularization of CCS patients must be postponed in low- to intermediate-risk patients |
| Postponing of non-invasive testing of CCS patients should be considered during COVID-19 pandemic |
| CT angiography should be preferred to non-invasive functional testing during COVID-19 pandemic |
| Screening for SARS-CoV-2 infection should be considered before cardiac surgery with nasopharyngeal swab and CT scan |
| Revascularization of high-riska CCS patients may be considered during COVID-19 pandemic |
| PCI may be considered over CABG in selected patients during COVID-19 pandemicb |
| Identification of COVID-19-free hospitals may be considered as ‘Hub’ for cardiac surgery |
| Invasive management of CCS in SARS-CoV-2-positive patients should be deferred until the patient has recovered, whenever possible |
CABG, coronary artery bypass graft; CCS, chronic coronary syndrome; COVID-19, coronavirus disease 2019; CT, computed tomography; ICU, intensive care unit; PCI, percutaneous coronary intervention; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
a
Patients with high-risk symptoms and/or coronary anatomy and/or large ischaemia as assessed by Heart team.
b
To shorten hospital stay and keep ICU beds available for patients with COVID-19.